Price
$15.91
1M+15%1Y-
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Not rated
P/E (TTM)-
Market Cap$2.10B
1Y Return-
5Y Return-
Generate Biomedicines, Inc. (GENB) reported revenue of $6.3M in Q2 2026 (quarter ended Jun 30, 2026), down 28% from the same quarter a year earlier. That came with net loss of $67M.
Raw charts
6 series · TTMAs reported to the SEC, without any scoring.
Biotechnology
The closest names by size in the same industry